AI assistant
Sending…
CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2015
Aug 27, 2015
31542_dirs_2015-08-27_3d090adf-2f1e-4bc5-a875-cca2ad1db15f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2015-08-25
Reporting Person: Miller Steve (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-08-25 | Common stock, par value $0.001 per share | M | 60000 | $1.09 | Acquired | 449754 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-08-25 | Options to purchase common stock | $1.09 | M | 60000 | Disposed | 2015-11-05 | Common Stock (60000) | Direct |
Footnotes
F1: The option was granted on November 5, 2010 and vested in three equal annual installments.
More from CATALYST PHARMACEUTICALS, INC.
M&A Activity
2026
Jun 8
Report Publication Announcement
2026
May 11
M&A Activity
2026
May 7
Major Shareholding Notification
2026
Mar 26
Earnings Release
2026
Feb 25
Annual Report
2026
Feb 25
Director's Dealing
2026
Feb 19
Investor Presentation
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6